Multi-omics Uncovering Different Faces of Clear Cell Ovarian Cancer.


Journal

Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500

Informations de publication

Date de publication:
14 11 2022
Historique:
received: 15 08 2022
revised: 27 08 2022
accepted: 02 09 2022
pubmed: 13 9 2022
medline: 16 11 2022
entrez: 12 9 2022
Statut: ppublish

Résumé

The diagnosis of clear cell ovarian cancer relies on expert histopathology review. Further characterization from deep genomic and transcriptomic analyses can identify different subgroups. International collaboration is required to define the clinical impact and therapy opportunities in these specific subclassifications. See related article by Bolton et al., p. 4947.

Identifiants

pubmed: 36094332
pii: 709169
doi: 10.1158/1078-0432.CCR-22-2365
doi:

Types de publication

Editorial Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

4838-4839

Commentaires et corrections

Type : CommentOn

Informations de copyright

©2022 American Association for Cancer Research.

Auteurs

Stephanie Lheureux (S)

Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH